Skip to content
healthcare.dev

Foscarnet

NDC 63323-875, foscarnet sodium, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-875
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212483
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-875 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FOSCARNET SODIUM24 mg/mL

Pharmacologic classes

Chelating Activity [MoA]; DNA Polymerase Inhibitors [MoA]; Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]; Pyrophosphate Analog [EXT]

Package NDCNDC-11Package
63323-875-50633230875501 BOTTLE in 1 CARTON (63323-875-50) / 250 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/335f7deb-a045-43cb-b319-d7b73bfda73c
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63323-875

Use it

Look up 63323-875 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-875 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-875. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.